2P16 | Hydrolase | date | Mar 02, 2007 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Factor Xa In Complex With The Inhibitor Apixaban (Bms-562247 (4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxo-1-Piperidinyl)Phenyl)-4 Tetrahydro-1h-Pyrazolo[3, 4-C]Pyridine-3-Carboxamide | ||||||||||||||
authors | R.Alexander | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Coagulation Factor X (Ec 3.4.21.6) (Stuart Factor Prower Factor); Chain: A Fragment: Coagulation Factor X, Heavy Chain Synonym: Factor Xa Heavy Chain, Activated Factor Xa Heavy C Ec: 3.4.21.6 |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 | ||||||||||||||
Molecule: Coagulation Factor X (Ec 3.4.21.6) (Stuart Factor Prower Factor); Chain: L Fragment: Coagulation Factor X, Light Chain Synonym: Factor Xa Light Chain Ec: 3.4.21.6 |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Other_details: Proteolytic Cleavage Product | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.30 Å | ||||||||||||
ligand | CA, GG2 BindingDB | enzyme | Hydrolase E.C.3.4.21.6 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Discovery of 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrah ydro- 1H-pyrazolo[3,4-c]pyridine-3-carboxamide (Apixaban, BMS-562247), a Highly Potent, Selective, Efficacious, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa., Pinto DJ, Orwat MJ, Koch S, Rossi KA, Alexander RS, Smallwood A, Wong PC, Rendina AR, Luettgen JM, Knabb RM, He K, Xin B, Wexler RR, Lam PY, J Med Chem. 2007 Oct 3;. PMID:17914785 |
Data retrieval |
View 2P16 in 3D |
Visual 3D analysis of 2P16 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 2P16 |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |